Your browser doesn't support javascript.
loading
The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis.
Klebe, Sonja; Nakatani, Yukio; Dobra, Katalin; Butnor, Kelly J; Roden, Anja C; Nicholson, Andrew G; Marchevsky, Alberto M; Husain, Aliya N; Segal, Amanda; Walts, Ann E; Weynand, Birgit; Michael, Claire W; Dacic, Sanja; Godbolt, David; Attanoos, Richard; Santoni-Rugiu, Eric; Galateau-Salle, Françoise; Hiroshima, Kenzo; Moreira, Andre L; Burn, Juliet; Nabeshima, Kazuki; Gibbs, Allen R; Churg, Andrew; Litzky, Leslie A; Brcic, Luka; Tsao, Ming Sound; Mino-Kenudson, Mari; Rørvig, Sara B; Tazelaar, Henry D; Krausz, Thomas; Zhang, Yu Zhi; Chirieac, Lucian R; Beasley, Mary B; Hjerpe, Anders.
Affiliation
  • Klebe S; Department of Anatomical Pathology, Flinders University and SA Pathology, Adelaide, SA, Australia. Electronic address: sonja.klebe@sa.gov.au.
  • Nakatani Y; Department of Pathology, Chiba University Hospital, Chiba, Japan.
  • Dobra K; Department of Laboratory Medicine, Division of Pathology, Karolinska University Hospital, Stockholm, Sweden.
  • Butnor KJ; Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, VT, USA.
  • Roden AC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Nicholson AG; Royal Brompton and Harefield NHS Foundation Trust, London, UK; National Heart and Lung Institute, Imperial College London, UK.
  • Marchevsky AM; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Husain AN; Department of Pathology, University of Chicago, Chicago, IL, USA.
  • Segal A; PathWest, Queen Elizabeth II Medical Centre, Perth, WA, Australia.
  • Walts AE; Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Weynand B; Department of Pathology, University Hospital Leuven, Leuven, Belgium.
  • Michael CW; Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH, USA; Department of Pathology, Case Western Reserve University, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
  • Dacic S; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Godbolt D; Department of Pathology, The Prince Charles Hospital, Brisbane, Qld, Australia.
  • Attanoos R; Department of Cellular Pathology, University Hospital of Wales, Cardiff, Wales, UK.
  • Santoni-Rugiu E; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
  • Galateau-Salle F; Department of Biopathology, Centre Léon Bérard, Lyon, France.
  • Hiroshima K; Department of Pathology, Yachiyo Medical Center, Tokyo Women's Medical University, Yachiyo, Japan; Department of Biochemistry and Genetics, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Moreira AL; Department of Pathology, NYU Langone Health, New York, NY, USA.
  • Burn J; Douglass Hanly Moir Pathology, Sydney, NSW, Australia.
  • Nabeshima K; Department of Pathology, Fukuoka University School of Medicine and Hospital, Fukuoka, Japan.
  • Gibbs AR; Department of Cellular Pathology, Cardiff and Vale University Health Board, Cardiff, Wales, UK.
  • Churg A; Department of Pathology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
  • Litzky LA; Department of Pathology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Brcic L; Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.
  • Tsao MS; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  • Mino-Kenudson M; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Rørvig SB; Department of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Tazelaar HD; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Krausz T; Department of Pathology, University of Chicago, Chicago, IL, USA.
  • Zhang YZ; Royal Brompton and Harefield NHS Foundation Trust, London, UK; National Heart and Lung Institute, Imperial College London, UK.
  • Chirieac LR; Harvard Medical School, Boston, MA, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Beasley MB; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Hjerpe A; Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Division of Clinical Pathology/Cytology, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden.
Pathology ; 53(4): 446-453, 2021 Jun.
Article in En | MEDLINE | ID: mdl-33775406
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Mesothelioma, Malignant Type of study: Diagnostic_studies / Guideline / Qualitative_research / Screening_studies Limits: Humans Language: En Journal: Pathology Year: 2021 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Mesothelioma, Malignant Type of study: Diagnostic_studies / Guideline / Qualitative_research / Screening_studies Limits: Humans Language: En Journal: Pathology Year: 2021 Type: Article